Psoriasis Clinical Trial
A Pilot Study to Explore the Role of Gut Flora in Psoriasis
Summary
This study seeks to correlate microbiome sequencing data with information provided by patients and their medical records regarding Psoriasis.
Full Description
The goal of this Research Study is to better understand how the genetic information in subject's microbiome correlates to the information provided in surveys and in medical records regarding Psoriasis
Eligibility Criteria
Inclusion Criteria:
Signed informed consent by patient
Male or female patients age 18 and older.
Diagnosis of Psoriasis based on PSAI of greater than or equal to 12 at screening
Exclusion Criteria:
Refusal by patient to sign informed consent form
Treatment with antibiotics within 2 weeks prior to screening
Treatment with probiotics within 6 weeks prior to screening
History of bariatric surgery, total colectomy with ileorectal anastomosis or proctocolectomy.
Postoperative stoma, ostomy, or ileoanal pouch
Participation in any experimental drug protocol within the past 12 weeks
Treatment with total parenteral nutrition
Any clinically significant evidence of disease that could interfere with the subject's ability to enter the trial
Inability of patient to adequately communicate with the investigator or their respective designee and/or comply with the requirements of the entire study
Check Your Eligibility
Let’s see if you might be eligible for this study.
What is your age and gender ?
There is 1 Location for this study
Ventura California, 93003, United States More Info
Principal Investigator
How clear is this clinincal trial information?
Please confirm you are a US based health care provider:
Yes, I am a health care Provider No, I am not a health care providerSign Up Now.
Take Control of Your Disease Journey.
Sign up now for expert patient guides, personalized treatment options, and cutting-edge insights that can help you push for the best care plan.